Fully human antibodies for any target
4-Antibody’s proprietary 4mAb™ platform technology uses a unique protocol to produce fully human monoclonal antibodies for any antigen target. The technology has the advantage of combining the proven strengths of the current gold standards of antibody discovery (phage display and transgenic mice), having the flexibility of in vitro library screening and antibody expression, while also benefiting from the natural in vivo antibody affinity maturation processes that ensure high affinity antigen binding.